XML 32 R21.htm IDEA: XBRL DOCUMENT
v3.20.2

Net Income Attributable To IPG Photonics Corporation Per Share | 9 Months Ended
--- | ---
Sep. 30, 2020
Earnings Per Share [Abstract] |
Net Income Attributable To IPG Photonics Corporation Per Share | NET INCOME ATTRIBUTABLE TO IPG PHOTONICS CORPORATION PER SHARE The following table sets forth the computation of diluted net income attributable to IPG Photonics Corporation per share:
| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2020 |  | 2019 |  | 2020 |  | 2019
Net income attributable to IPG Photonics Corporation | $ | 35,604 |  |  | $ | 57,253 |  |  | $ | 110,233 |  |  | $ | 184,684 |
Net income attributable to common stockholders | 35,604 |  |  | 57,253 |  |  | 110,233 |  |  | 184,684 |
Weighted average shares | 53,098 |  |  | 52,928 |  |  | 53,136 |  |  | 53,073 |
Dilutive effect of common stock equivalents | 566 |  |  | 694 |  |  | 555 |  |  | 791 |
Diluted weighted average common shares | 53,664 |  |  | 53,622 |  |  | 53,691 |  |  | 53,864 |
Basic net income attributable to IPG Photonics Corporation per share | $ | 0.67 |  |  | $ | 1.08 |  |  | $ | 2.07 |  |  | $ | 3.48 |
Basic net income attributable to common stockholders | $ | 0.67 |  |  | $ | 1.08 |  |  | $ | 2.07 |  |  | $ | 3.48 |
Diluted net income attributable to IPG Photonics Corporation per share | $ | 0.66 |  |  | $ | 1.07 |  |  | $ | 2.05 |  |  | $ | 3.43 |
Diluted net income attributable to common stockholders | $ | 0.66 |  |  | $ | 1.07 |  |  | $ | 2.05 |  |  | $ | 3.43 |
The computation of diluted weighted average common shares excludes common stock equivalents including non-qualified stock options, performance stock units ("PSU's"), restricted stock units ("RSU's") and employee stock purchase plan ("ESPP") because the effect of including them would be anti-dilutive. The weighted average anti-dilutive shares outstanding for the three and nine months ended September 30, 2020 and 2019 were as follows:
| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2020 |  | 2019 |  | 2020 |  | 2019
Non-qualified stock options | 528,300 |  |  | 763,000 |  |  | 555,800 |  |  | 578,000 |
Restricted stock units | 28,900 |  |  | 167,200 |  |  | 36,200 |  |  | 149,200 |
Performance stock units | — |  |  | 45,500 |  |  | 19,800 |  |  | 40,800 |
Employee stock purchase plan | 5,500 |  |  | 6,100 |  |  | 16,400 |  |  | 18,200 |
Total weighed average anti-dilutive shares outstanding | 562,700 |  |  | 981,800 |  |  | 628,200 |  |  | 786,200 |
On May 5, 2020, the Company announced that its Board of Directors authorized the purchase of up to $200,000 of IPG common stock. This new authorization is additive to the Company's existing stock repurchase of $125,000 repurchase program authorized in February 2019. Under the two share purchase authorizations, IPG may repurchase shares of common stock (a) in an amount not to exceed the lesser of the number of shares issued to employees and directors under the Company's various employee and director equity compensation and employee stock purchase plans in 2019 and 2020 or $125,000 and (b) $200,000, in both cases exclusive of any fees, commissions or other expenses. Share repurchases may be made periodically in open-market transactions using the Company's working capital and are subject to market conditions, legal requirements and other factors. The share purchase program authorization does not obligate the Company to repurchase any dollar amount or number of its shares, and repurchases may be commenced or suspended from time to time without prior notice. For the three months ended September 30, 2020, the Company repurchased 61,472 shares of common stock under the February 2019 authorization with an average price of $157.01 per share in the open market. The impact on the reduction of weighted average shares for the three months ended September 30, 2020 was 22,842 shares. For the nine months ended September 30, 2020, the Company repurchased 301,660 shares of common stock under the February 2019 authorization with an average price of $125.58 per share in the open market. The impact on the reduction of weighted average shares for the nine months ended September 30, 2020 was 155,372 shares. As of September 30, 2020 the remaining amount authorized under the programs was up to $246,000, but may be less depending upon the equity compensation and employee stock purchase plan dilution during the programs.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI http://asc.fasb.org/topic&trid=2144383 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration